Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

967 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Angiotensin receptor blocker-based therapy and cardiovascular events in hypertensive patients with coronary artery disease and impaired renal function.
Shiga T, Kasanuki H, Hagiwara N, Sumiyoshi T, Honda T, Haze K, Takagi A, Kawana M, Origasa H, Ogawa H; Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease (Hij-Create) Investigators. Shiga T, et al. Among authors: takagi a. Blood Press. 2010 Dec;19(6):359-65. doi: 10.3109/08037051003802475. Epub 2010 May 24. Blood Press. 2010. PMID: 20491606 Free article. Clinical Trial.
Effect of amlodipine + candesartan on cardiovascular events in hypertensive patients with coronary artery disease (from The Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease [HIJ-CREATE] Study).
Yamaguchi J, Hagiwara N, Ogawa H, Koyanagi R, Kasanuki H, Takagi A, Mori F, Nagashima M, Yagi M; HIJ-CREATE Investigators. Yamaguchi J, et al. Among authors: takagi a. Am J Cardiol. 2010 Sep 15;106(6):819-24. doi: 10.1016/j.amjcard.2010.05.007. Epub 2010 Aug 2. Am J Cardiol. 2010. PMID: 20816122 Clinical Trial.
Efficacy of paclitaxel-eluting stent implantation in hemodialysis patients.
Higashitani M, Mori F, Yamada N, Arashi H, Kojika A, Hoshi H, Minami Y, Yamaguchi J, Yamauchi T, Takagi A, Ogawa H, Hagiwara N. Higashitani M, et al. Among authors: takagi a. Heart Vessels. 2011 Nov;26(6):582-9. doi: 10.1007/s00380-010-0110-4. Epub 2011 Jan 26. Heart Vessels. 2011. PMID: 21267582
Chronic kidney disease and long-term outcomes of myocardial infarction.
Nagashima M, Hagiwara N, Koyanagi R, Yamaguchi J, Takagi A, Kawada-Watanabe E, Shiga T, Ogawa H. Nagashima M, et al. Among authors: takagi a. Int J Cardiol. 2013 Sep 10;167(6):2490-5. doi: 10.1016/j.ijcard.2012.04.049. Epub 2012 May 7. Int J Cardiol. 2013. PMID: 22569317
Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: results from the HIJAMI-II registry.
Shiga T, Hagiwara N, Ogawa H, Takagi A, Nagashima M, Yamauchi T, Tsurumi Y, Koyanagi R, Kasanuki H; Heart Institute of Japan Acute Myocardial Infarction-II (HIJAMI-II) Investigators. Shiga T, et al. Among authors: takagi a. Heart. 2009 Mar;95(3):216-20. doi: 10.1136/hrt.2008.145243. Epub 2008 Aug 26. Heart. 2009. PMID: 18728065
967 results